Interleukin-22 serum levels are a negative prognostic indicator in patients with hepatocellular carcinoma

Hepatology. 2014 Mar;59(3):1207. doi: 10.1002/hep.26528. Epub 2013 Dec 13.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Animals
  • Carcinoma, Hepatocellular / etiology*
  • Female
  • Humans
  • Interleukins / physiology*
  • Liver Neoplasms / etiology*
  • Male
  • STAT3 Transcription Factor / physiology*

Substances

  • Interleukins
  • STAT3 Transcription Factor